P

Proactive Clinical Research, LLC | Edinburg, TX

Research site

(Unclaimed)

Location

2613 West Trenton Road, Edinburg, Texas, United States of America

Site insights

Top conditions

Top treatments

Dulaglutide

Orforglipron

PF-07817883

LY3502970

Parent organization

This site is a part of Proactive Clinical Research, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 11 total trials

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants

The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20...

Active, not recruiting

Pneumococcal Vaccines

Biological: 0.5 mL of the mid dose VAX-31

Biological: 0.5 mL of the High-PFS dose VAX-31

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes (ACHIEVE-PEDS)

This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 t...

Begins enrollment this month

Diabetes Mellitus, Type 2

Drug: Orforglipron

Drug: Dulaglutide

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling

Pneumococcal Disease

Biological: PG4

Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcu...

Enrolling

Healthy

Biological: Infanrix hexa

Biological: Prevnar 20